147 related articles for article (PubMed ID: 2153635)
1. Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate.
Lorico A; Boiocchi M; Rappa G; Sen S; Erba E; D'Incalci M
Int J Cancer; 1990 Jan; 45(1):156-62. PubMed ID: 2153635
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin.
Erba E; Sen S; Lorico A; D'Incalci M
Eur J Cancer; 1992; 28(1):66-71. PubMed ID: 1314631
[TBL] [Abstract][Full Text] [Related]
3. Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Holden SA; Teicher BA; Robinson MF; Northey D; Rosowsky A
Cancer Chemother Pharmacol; 1995; 36(2):165-71. PubMed ID: 7767954
[TBL] [Abstract][Full Text] [Related]
4. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of topoisomerase II: structure-activity relationships and mechanism of action of podophyllin congeners.
Long BH; Stringfellow DA
Adv Enzyme Regul; 1988; 27():223-56. PubMed ID: 2854948
[TBL] [Abstract][Full Text] [Related]
6. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine.
Chresta CM; Hicks R; Hartley JA; Souhami RL
Cancer Chemother Pharmacol; 1992; 31(2):139-45. PubMed ID: 1333370
[TBL] [Abstract][Full Text] [Related]
8. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors.
Binaschi M; Capranico G; De Isabella P; Mariani M; Supino R; Tinelli S; Zunino F
Int J Cancer; 1990 Feb; 45(2):347-52. PubMed ID: 2154411
[TBL] [Abstract][Full Text] [Related]
9. Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues.
Duran GE; Lau DH; Lewis AD; Kühl JS; Bämmler TK; Sikic BI
Cancer Chemother Pharmacol; 1996; 38(3):210-6. PubMed ID: 8646794
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
Halicka HD; Ardelt B; Li X; Melamed MM; Darzynkiewicz Z
Cancer Res; 1995 Jan; 55(2):444-9. PubMed ID: 7812976
[TBL] [Abstract][Full Text] [Related]
11. hMRE11 plays an important role in U937 cellular response to DNA double-strand breaks following etoposide.
Liu LB; Tian L; Li WM; Li L; Wang L; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):10-5. PubMed ID: 17490511
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
Jpn J Cancer Res; 1992 Nov; 83(11):1132-6. PubMed ID: 1336489
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells.
Nakaya K; Chou S; Kaneko M; Nakamura Y
Jpn J Cancer Res; 1991 Feb; 82(2):184-91. PubMed ID: 1848545
[TBL] [Abstract][Full Text] [Related]
14. Induction of DNA double-strand breaks by 8-methoxycaffeine: cell cycle dependence and comparison with topoisomerase II inhibitors.
Russo P; Cimoli G; Valenti M; De Sessa F; Parodi S; Pommier Y
Carcinogenesis; 1994 Nov; 15(11):2491-6. PubMed ID: 7955097
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavable complexes.
Dynlacht JR; Wong RS; Albright N; Dewey WC
Cancer Res; 1994 Aug; 54(15):4129-37. PubMed ID: 8033146
[TBL] [Abstract][Full Text] [Related]
16. A topoisomerase II inhibitor, NK109, induces DNA single- and double-strand breaks and apoptosis.
Fukuda M; Inomata M; Nishio K; Fukuoka K; Kanzawa F; Arioka H; Ishida T; Fukumoto H; Kurokawa H; Oka M; Saijo N
Jpn J Cancer Res; 1996 Oct; 87(10):1086-91. PubMed ID: 8957068
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia, thermotolerance and topoisomerase II inhibitors.
Kampinga HH
Br J Cancer; 1995 Aug; 72(2):333-8. PubMed ID: 7640214
[TBL] [Abstract][Full Text] [Related]
18. DNA damage induced by etoposide; a comparison of two different methods for determination of strand breaks in DNA.
Walles SA; Zhou R; Liliemark E
Cancer Lett; 1996 Aug; 105(2):153-9. PubMed ID: 8697438
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
Taylor IW; Tattersall MH
Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
[TBL] [Abstract][Full Text] [Related]
20. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
